Journal
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
Volume 195, Issue 1, Pages 149-153Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.ajog.2006.01.065
Keywords
asthma; pregnancy; medicaid database; drug utilization; guidelines
Categories
Funding
- AHRQ HHS [U18-HS10384] Funding Source: Medline
- NCRR NIH HHS [MO1 RR00095] Funding Source: Medline
- NHLBI NIH HHS [UO1 HL 72471] Funding Source: Medline
- NIAID NIH HHS [KO8 AI01582] Funding Source: Medline
Ask authors/readers for more resources
Objective: The objective of the study was to determine whether women alter their use of asthma medications during pregnancy. Study design: Weekly asthma medication use was determined from prescription claims data in a cohort of 112,171 pregnant women aged 15 to 44 years who were continuously enrolled in the Tennessee Medicaid program prior to their singleton pregnancy and who delivered a singleton birth during 1995 to 2001. Change in asthma medication use was evaluated using generalized estimating equation analyses. Results: Women with asthma significantly (P <= 0.0005) decreased their asthma medication use from 5 to 13 weeks of pregnancy., During the first trimester, there was a 23% decline in inhaled corticosteroid prescriptions, a 13% decline in short-acting beta-agonist prescriptions, and a 54% decline in rescue corticosteroid prescriptions. Conclusions: Utilization of all categories of asthma medications decreased in early pregnancy, with the largest declines occurring for inhaled and rescue corticosteroids. (c) 2006 Mosby, Inc. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available